Savara’s $100M offering; New biotech to test Eisai drug in Ph2

Plus, news about Dai­ichi Sankyo, Seagen, Lan­theus, Life Mol­e­c­u­lar Imag­ing, Astel­las Gene Ther­a­pies, Eli Lil­ly and Apari­to:

Savara prices $100M of­fer­ing: The Lang­horne, PA-based biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.